Henry Schein, Inc. (NASDAQ:HSIC)’s share price fell 2.9% during mid-day trading on Friday . The company traded as low as $82.16 and last traded at $82.88. 2,924,030 shares changed hands during trading, an increase of 499% from the average session volume of 488,119 shares. The stock had previously closed at $80.57.

A number of research firms have recently issued reports on HSIC. UBS AG reissued a “buy” rating on shares of Henry Schein in a research report on Friday. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday. Credit Suisse Group reissued a “hold” rating and set a $87.50 price objective on shares of Henry Schein in a research report on Tuesday, August 29th. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Finally, Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective on the stock in a research report on Monday, August 7th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the company. Henry Schein currently has an average rating of “Hold” and a consensus target price of $93.30.

The firm has a 50 day moving average price of $170.49 and a 200-day moving average price of $175.55. The firm has a market cap of $6.55 billion, a P/E ratio of 12.11 and a beta of 1.10.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.82 EPS. Equities research analysts expect that Henry Schein, Inc. will post $7.27 earnings per share for the current fiscal year.

In other news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.27% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Bronfman E.L. Rothschild L.P. boosted its stake in Henry Schein by 4.0% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 14,859 shares of the company’s stock worth $2,719,000 after acquiring an additional 566 shares in the last quarter. Intrust Bank NA boosted its stake in Henry Schein by 1.1% during the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock worth $223,000 after acquiring an additional 13 shares in the last quarter. Bluestein R H & Co. boosted its stake in Henry Schein by 22.5% during the first quarter. Bluestein R H & Co. now owns 123,224 shares of the company’s stock worth $20,944,000 after acquiring an additional 22,608 shares in the last quarter. BlackRock Inc. boosted its stake in Henry Schein by 2,999.6% during the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock worth $951,028,000 after acquiring an additional 5,414,761 shares in the last quarter. Finally, Comerica Bank boosted its stake in Henry Schein by 10.6% during the second quarter. Comerica Bank now owns 21,833 shares of the company’s stock worth $4,054,000 after acquiring an additional 2,101 shares in the last quarter. 89.11% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Henry Schein, Inc. (HSIC) Stock Price Down 2.9%” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/09/17/henry-schein-inc-hsic-stock-price-down-2-9.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.